AI assistant
Sending…
FATE THERAPEUTICS INC — Director's Dealing 2013
Oct 7, 2013
34091_dirs_2013-10-07_a80f2343-d960-4dd0-828a-62061d267e09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2013-10-04
Reporting Person: RASTETTER WILLIAM H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-04 | Common Stock | P | 83333 | $6 | Acquired | 83333 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 118360 | Indirect |
Footnotes
F1: These shares are owned of record by The Investment 2002 Trust dated 11/11/02 for which William H. Rastetter is the sole trustee and owner.
F2: These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.
More from FATE THERAPEUTICS INC
Report Publication Announcement
2026
Jun 4
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 24
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 12